Ушбу иш иқтибос қилган ишлар

111 та иш

Иш: The microbiome and precision oncology: an emerging paradigm in anticancer therapy

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67
Мақола20176 иқтибос
ABI
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45
Мақола20175 иқтибос
ABI
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo González, Catharina Hagerling, Zena Werb
Шарҳ мақола20184 иқтибос
ABI
The Human Microbiome Project
Peter J. Turnbaugh, Ruth E. Ley, Micah Hamady +3
Мақола20073 иқтибос
ABI
One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
Haoyi Wang, Hui Yang, Chikdu Shivalila +4
Мақола20133 иқтибос
ABI
Human papillomavirus and cervical cancer
Mark Schiffman, Philip E. Castle, José Jerónimo +2
Шарҳ мақола20073 иқтибос
ABI
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vétizou, Jonathan M. Pitt, Romain Daillère +35
Мақола20153 иқтибос
ABI
Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans
Ron Sender, Shai Fuchs, Ron Milo
Мақола20163 иқтибос
ABI
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
Vyara Matson, Jessica Fessler, Riyue Bao +5
Мақола20183 иқтибос
ABI
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Bret D. Wallace, Hongwei Wang, Kimberly T. Lane +8
Мақола20103 иқтибос
ABI
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Romain Daillère, Marie Vétizou, Nadine Waldschmitt +33
Мақола20163 иқтибос
ABI
Cancer statistics, 2020
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal
Мақола20203 иқтибос
ABI
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
Sandra Demaria, Bruce Ng, M. Devitt +4
Мақола20042 иқтибос
ABI
The future of immune checkpoint therapy
Padmanee Sharma, James P. Allison
Шарҳ мақола20152 иқтибос
ABI
Gut biogeography of the bacterial microbiota
Gregory P. Donaldson, S. Melanie Lee, Sarkis K. Mazmanian
Шарҳ мақола20152 иқтибос
ABI
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
Leonard B. Saltz, John V. Cox, Charles D. Blanke +9
Мақола20002 иқтибос
ABI
Doxorubicin: The Good, the Bad and the Ugly Effect
Cristina Carvalho, Renato X. Santos, Susana Cardoso +4
Шарҳ мақола20092 иқтибос
ABI
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud, Fabiana Saccheri, Grégoire Mignot +30
Мақола20132 иқтибос
ABI
Commensal <i>Bifidobacterium</i> promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Ayelet Sivan, Leticia Corrales, Nathaniel Hubert +9
Мақола20152 иқтибос
ABI
Anticancer effects of the microbiome and its products
Laurence Zitvogel, Romain Daillère, María Paula Roberti +2
Шарҳ мақола20172 иқтибос
ABI
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma, David Miles, Luca Gianni +11
Мақола20122 иқтибос
ABI
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Deborah Nejman, Ilana Livyatan, Garold Fuks +58
Мақола20202 иқтибос
ABI
Tumor-Associated Microbiome: Where Do We Stand?
Marc Oliva, Núria Mulet-Margalef, María Ochoa-de-Olza +7
Шарҳ мақола20212 иқтибос
ABI
Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
Yao He, Liuhui Fu, Yiping Li +10
Мақола20212 иқтибос
ABI
Bacterial infection as a cause of cancer.
Julie Parsonnet
Шарҳ мақола19952 иқтибос
ABI